Total and differential leukocytes counts, but not hsCRP, ESR, and five fractioned serum proteins have significant potency to predict stable coronary artery disease

Clinica Chimica Acta

Volumn 377, Issue 1-2, 2007, Pages 127-132

  Rasouli, Mehdi ^a   Kiasari, Asadollah Mohseni ^a   Bagheri, Babak ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CAD; Diabetes; hsCRP; Inflammation; Leukocyte; Serum proteins

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; PLASMA PROTEIN;

ADULT; ANGIOCARDIOGRAPHY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROPHORESIS; EOSINOPHIL; EOSINOPHIL COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LIPOPROTEIN BLOOD LEVEL; LOGISTIC REGRESSION ANALYSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; NEUTROPHIL; NEUTROPHIL COUNT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PROTEINS; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LEUKOCYTES; MALE; MIDDLE AGED;

EID: 33845385273     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.09.009     Document Type: Article

References (33)

1. Danesh J., Collins R., Appleby P., and Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 279 (1998) 1477-1483
2. Zebrack J.S., Muhlestein J.B., Horne B.D., and Anderson J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39 (2002) 632-639
3. Folsom A.R., Aleksic N., Catellier D., Juneja H.S., and Wu K.K. C-Reactive protein and incident coronary heart disease in the Atherosclerosis Risk In Communities (ARIC) study. Am Heart J 144 (2002) 233-238
4. Levinson S.S., Miller J.J., and Elin R.J. Poor predictive value of hsCRP indicates need for reassessment. Clin Chem 50 (2004) 1733-1735
5. Hunt M.E., O'Malley P.G., Vernalis M.N., Feuerstein I.M., and Taylor A.J. C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis. Am Heart J 141 (2001) 206-210
6. Veselka J., Prochazkova S., Duchonova R., et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13 (2002) 151-154
7. Hoffmeister A., Rothenbacher D., Bazner U., et al. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87 (2001) 262-266
8. Zebrack J.S., Anderson J.L., Maycock C.A., Horne B.D., Bair T.L., and Muhlestein J.B. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 89 (2002) 145-149
9. Folsom A.R., Pankow J.S., Tracy R.P., et al. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 88 (2001) 112-117
10. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1397
11. Phillips A.N., Neaton J.D., Cook D.G., Grimm R.H., and Shaper A.G. Leukocyte count and risk of major coronary heart disease events. Am J Epidemiol 136 (1992) 59-70
12. Gillum R.F., Mussolino M.E., and Madans J.H. Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann Epidemiol 15 (2005) 266-271
13. Madjid M., Awan I., Willerson J.T., and Casscells S.W. Leukocyte count and coronary heart disease. Implications for risk assessment. J Am Coll Cardiol 44 (2004) 1946-1956
14. Brown D.W., Giles W.H., and Croft J.B. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 54 (2001) 316-322
15. Wheeler J.G., Mussolino M.E., Gillum R.F., and Danesh J. Associations between differential leucocyte count and incident coronary heart disease: 1764 incident cases from seven prospective studies of 30,374 individuals. Eur Heart J 25 (2004) 1287-1292
16. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J Am Coll Cardiol 45 (2005) 1639-1643
17. Kawaguchi H., Mori T., Kawano T., Kono S., Sasaki J., and Arakawa K. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am Heart J 132 (1996) 9-12
18. Godsland I.F., Bruce R., Jeff J.A.R., Leyva F., Walton C., and Stevenson J.C. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Intern J Cardiol 97 (2004) 543-550
19. Danesh J., Collins R., Peto R., and Lowe G.D. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21 (2000) 513-514
20. Danesh J., Muir J., Wong Y.K., Ward M., Gallimore J.R., and Pepys M.B. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 20 (1999) 954-959
21. Mori T., Sasaki J., Kawaguchi H., et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129 (1995) 234-238
22. Delanghe J.R., Langlois M.R., De Bacquer D., et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 160 (2002) 471-476
23. Abdelmouttaleb I., Danchin N., Ilardo C., et al. C-reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 137 (1999) 346-351
24. Blake G.J., and Ridker P.M. C-Reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 (2003) 37S-42S
25. Taniguchi H., Momiyama Y., Ohmori R., et al. Associations of plasma C-reactive protein concentrations with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178 (2005) 173-177
26. Maat M.P.M., and Kluft C. The association between inflammation markers, coronary artery disease and smoking. Vasc Pharm 39 (2002) 137-139
27. Aronson D., Goldberg A., Roguin A., et al. Effect of obesity on the relationship between plasma C-reactive protein and coronary artery stenosis in patients with stable angina. Atherosclerosis 185 (2006) 137-142
28. Rasouli M., and Mohseni A.K. Multiplicative interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Clin Biochem 39 (2006) 971-977
29. Rasouli M., Okhovatian A., and Enderami A. Serum proteins profile as an indicator of malignancy: multivariate logistic regression and ROC analyses. Clin Chem Lab Med 43 (2005) 913-918
30. Chenillot O., Henny J., Steinmetz J., Herbeth B., Wagner C., and Siets G. High sensitivity C-reactive protein: biological variations and reference limits. Clin Chem Lab Med 38 (2000) 1003-1011
31. Sunyer J., Munoz A., Peng Y., et al. Longitudinal relation between smoking and white blood cells. Am J Epidemiol 144 (1996) 734-741
32. Piché M.P., Lemieux S., Weisnagel S.J., Corneau L., Nadeau A., and Bergeron J. Relation of high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and fibrinogen to abdominal adipose tissue, blood pressure, and cholesterol and triglyceride concentrations in healthy postmenopausal women. Am J Cardiol 96 (2005) 92-97
33. Ommen S.R., Gibbons R.J., Hodge D.O., and Thomson S.J. Lymphocyte concentration, a new prognostic marker in coronary artery disease. J Am Coll Cardiol 25 (1995) 410A-411A